Peptides

Papers
(The H4-Index of Peptides is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
In silico design of antiviral peptides targeting the spike protein of SARS-CoV-284
Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists57
Chemical modifications to increase the therapeutic potential of antimicrobial peptides57
GIP has neuroprotective effects in Alzheimer and Parkinson’s disease models50
Nisin—A lantibiotic with immunomodulatory properties: A review49
The role of GIP in α-cells and glucagon secretion48
Intestinal glucagon-like peptide-1 effects on food intake: Physiological relevance and emerging mechanisms43
Immunomodulatory peptides—A promising source for novel functional food production and drug discovery38
The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)37
Antiviral peptides against Coronaviridae family: A review35
GIP analogues and the treatment of obesity-diabetes33
The critical role of CCK in the regulation of food intake and diet-induced obesity31
Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates31
Soybean proteins/peptides: A review on their importance, biosynthesis, vacuolar sorting, and accumulation in seeds31
An update on peptide-based therapies for type 2 diabetes and obesity30
Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”30
GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation29
Amylin brain circuitry28
Peptides to combat viral infectious diseases27
Molecular interactions of full-length and truncated GIP peptides with the GIP receptor – A comprehensive review27
An overview of the insulin signaling pathway in model organisms Drosophila melanogaster and Caenorhabditis elegans27
NUCB2/nesfatin-1 – Inhibitory effects on food intake, body weight and metabolism27
Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease27
Emerging role of GIP and related gut hormones in fertility and PCOS26
Strategies for improving stability and pharmacokinetic characteristics of radiolabeled peptides for imaging and therapy25
0.07887601852417